Research Panel

 
Stock Quotes for Research Panel top ^
  • Industry: Lumber & Wood Production
  • Sector: Basic Materials
  • Stock Style: Small Value
Sign-up for 526490 investment picks

 
News Articles for Research Panel top ^
2014/12/9
http://media.marketwire.com/attachments/201310/197574_GE_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163922&ProfileId=051205&sourceType=1 DALLAS, TX --
Sign-up for New GE 3U Distribution Panel Provides Higher Electrical Capacity in a More Compact Rack Design investment picks
2014/11/5
WILMINGTON, Del., Nov.
Sign-up for DuPont Packaging Announces Advisory Panel and Calls for Entries investment picks
Company Increases Commitment to this Region; Estimates 150 Local Jobs SAN JOSE, Calif.
Sign-up for SunPower Announces 160-Megawatt Solar Panel Manufacturing Facility in South Africa investment picks
2014/12/18
By Leslie Scism and Victoria McGrane Panel of federal regulators tags insurer for heightened oversight A panel of federal regulators Thursday concluded MetLife Inc. poses significant risks to the financial system and warrants tougher oversight, setting up a possible legal showdown with the U.S. about whether that assessment is accurate.
Sign-up for MetLife designated as 'systemically important' by U.S. panel investment picks
HIGHLANDS RANCH, Colo., Nov.
Sign-up for Advanced Emissions Solutions Receives Positive NASDAQ Panel Decision investment picks
Ensco (NYSE: ESV) announced today that CEO and President Carl Trowell will participate on an industry panel at the Goldman Sachs Global Energy Conference in Miami on Wednesday, 7 January 2015.
Sign-up for Ensco plc to Participate on an Industry Panel at Goldman Sachs Global Energy Conference investment picks
2015/1/20
By Angela Chen Six transportation experts will join former Secretary of Transportation Samuel Skinner on a panel to assess the practices of Takata Corp., the Japanese air bag company that came under scrutiny after its air bag explosions were linked to five deaths.
Sign-up for Takata Corp. Adds Six Experts to Review Panel investment picks
New 4000 series priced to bring benefits of IFP technology to even more classrooms SMART also expanding award-winning 6000 IFP series Flat panel technology leads to estimated lower cost of ownership compared to traditional, projector-based solutions Combination of SMART education hardware and software accelerates learning naturally through improved student collaboration, engagement and participation CALGARY , Jan.
Sign-up for SMART Technologies Unveils New Value Line of Interactive Flat Panel Displays for Education investment picks
SMART Technologies Unveils New Value Line of Interactive Flat Panel Displays for Education Canada NewsWire CALGARY , Jan.
Sign-up for SMART Technologies Unveils New Value Line of Interactive Flat Panel Displays for Education investment picks
Heartland Payment Systems (NYSE: HPY ), the nation's fifth largest payments processor and a leading provider of merchant business solutions, is sponsoring a keynote panel at the Restaurant Innovation Summit on industry outlook and trends.
Sign-up for Heartland Executive Director and Leaf CEO to Participate in Keynote Panel on the Future of Mobile Payments investment picks
2014/10/23
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Chinese solar-panel makers are having trouble meeting domestic demand, turning down some orders as their factories are running at capacity, analysts at Deutsche Bank said.
Sign-up for Chinese solar-panel makers race to fill orders investment picks
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a global producer of effective, natural microalgae nutritional supplements, announced the installation of its new solar array by Neighborhood Power Company (NPC). The 2,280 panel array sits on 1.3 acres of Cyanotech’s 90-acre microalgae farm, and will produce 1,147,000 kilowatt hours of electricity each year, which Cyanotech will purchase under a Power Purchase Agreement (PPA). The energy production is sufficient to power the entire farm’s production during daylight hours, and will reduce Cyanotech’s electricity costs by 10 percent.
Sign-up for Cyanotech Adds 2,280 Solar Array Panels; Reduces Greenhouse Emissions by 791 Metric Tons of Carbon Dioxide Per Year and Annual Electricity Costs by 10 Percent investment picks
Jacobs Engineering Group Inc. (NYSE:JEC) announced today that it is on a panel of three consultants responsible for delivering more than A$100 million (US$88 million) in airside capital expansion projects for the Brisbane Airport Corporation (BAC) in Brisbane, Australia.
Sign-up for Jacobs Awarded Contracts through Brisbane Airport Airside Panel investment picks
Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced today that Robert Forrester, Verastem President and Chief Executive Officer, will participate in a panel titled, “Live & Breathe: Building a Patient-Centered Biotech,” at the MassBio Patient Advocacy Summit on November 10, 2014 at 8:45 am ET at the Genzyme Center in Cambridge, MA.
Sign-up for Verastem to Participate in Panel at the MassBio Patient Advocacy Summit investment picks
BAODING, China , Nov.
Sign-up for Yingli Green Energy Supplies 72 MW of Solar Panels to Solarcentury in the United Kingdom investment picks
2014/12/3
By Christina Rogers Takata Corp.
Sign-up for Takata forms independent panel on air-bag defects investment picks
Only NGS-based panel for CLL that offers information for patient risk stratification, disease management, and treatment selection Focus::CLL addresses a significant market of over 120,000 patients in the US living with CLL, the most common form of leukemia in the Western hemisphere Focus::CLL is available for both routine patient diagnosis and management as well as clinical trials for CLL RUTHERFORD, N.J., Dec.
Sign-up for Cancer Genetics, Inc. Announces Launch of Targeted Next Generation Sequencing Based Panel for Chronic Lymphocytic Leukemia, Focus::CLL investment picks
Generic biotech drugs took one step closer to reality after a Food and Drug Administration advisory panel recommended the agency approve a Novartis AG (NVS) version of Amgen's Inc.'s (AMGN) drug Neupogen, according to media reports late Wednesday.
Sign-up for UPDATE: FDA panel recommends approval for first generic biotech drug investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Research Panel
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Output  |  Next: Research Paper